Skip to main content

BBS-Bioactive Bone Substitutes Plc: ANNUAL REPORT 2021 has been published

Written by Customer Service on . Posted in Public Companies.

Company release 29th March 2022, 4:30 PM

 

BBS Oyj’s Annual Report for 2021 has been published 29.3.2022. The Publication is attached to this release and can be found at https://www.bbs-artebone.fi/investors/financial-reports/ 

The Publication includes the English translation of the Annual Report and the Audited Financial Statements for 2021. The English translation of the Financial Statements for Financial Year 2021 is also available on company’s website at https://www.bbs-artebone.fi/investors/financial-reports/. 
 
More information: 
Ilkka Kangasniemi, CEO 
ilkka.kangasniemi@bbs-artebone.fi
+358 40 7080307 

Distribution: 
Nasdaq Helsinki Oy 
Nasdaq Stockholm AB
Main Media 
www.bbs-artebone.fi

BBS – Bioactive Bone Substitutes Plc 
BBS-Bioactive Bone Substitutes Plc is a Finnish orthobiologic biotech company. We have developed a new product for healing of difficult bone fractures and for solving the problems in bone healing. Our mission is to offer new generation medicinal products for the orthopedic 
surgery. The research and development in the field of medicine requires perseverance and courage to develop new things. We have over 20 years of expertise in this. Our operations are haracterised by top expertise, innovativeness and dedicated and committed employees. The 
first product, ARTEBONE® paste, is ready and the application process for the CE-marking enabling commercialization is in progress. 

More information: www.bbs-artebone.fi 
BBS-Bioactive Bone Substitutes Plc shares are listed on the Nasdaq First North Growth Market.

 

Attachments

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.